HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibitor kappaB and nuclear factor kappaB in granulocyte-macrophage colony-stimulating factor antagonism of dexamethasone suppression of the macrophage response to Aspergillus fumigatus conidia.

AbstractBACKGROUND:
The dexamethasone (DEX) immunosuppressive effect on macrophage killing activity and cytokine production in response to Aspergillus fumigatus conidia is antagonized by granulocyte-macrophage colony-stimulating factor (GM-CSF). The molecular mechanism is unknown. We postulated that this antagonism is mediated by inhibitor kappaB (I kappaB) induction by DEX and is opposed by acceleration of I kappaB degradation by GM-CSF with or without conidia stimulation, with corresponding effects on translocation and activation of nuclear factor kappa B (NF-kappaB).
METHODS:
We studied 2 types of cells, resident peritoneal macrophages from CD-1 mice and the murine macrophage RAW264.7 cell line. Cells were unstimulated or stimulated with conidia and simultaneously treated with DEX, GM-CSF, or DEX plus GM-CSF, for 2-4 hours. I kappaB degradation and NF-kappaB activation were assessed by Western blot.
RESULTS:
Macrophages stimulated with conidia alone increased NF-kappaB translocation. DEX increased I kappaB levels in cytoplasm and blocked translocation of NF-kappaB to the nucleus in unstimulated and conidia-stimulated macrophages. Conversely, GM-CSF decreased I kappaB levels. GM-CSF reversed the effect of DEX on I kappaB levels. NF-kappaB levels were minimal in DEX-treated macrophage nuclear extracts, compared with those from GM-CSF-treated and GM-CSF plus DEX-treated macrophages.
CONCLUSION:
GM-CSF can reverse the DEX immunosuppressive effect by enhancing I kappaB degradation and promoting NF-kappaB translocation. This would allow macrophage production of proinflammatory cytokines, facilitating resistance to aspergillosis.
AuthorsJung-Hyun Choi, Elmer Brummer, Young Jun Kang, Patricia P Jones, David A Stevens
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 193 Issue 7 Pg. 1023-8 (Apr 01 2006) ISSN: 0022-1899 [Print] United States
PMID16518765 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • IkappaBNS protein, mouse
  • Intracellular Signaling Peptides and Proteins
  • NF-kappa B p50 Subunit
  • Proteins
  • Nfkb1 protein, mouse
  • Dexamethasone
  • Granulocyte-Macrophage Colony-Stimulating Factor
Topics
  • Animals
  • Anti-Inflammatory Agents (antagonists & inhibitors, pharmacology)
  • Aspergillosis (immunology, microbiology)
  • Aspergillus fumigatus (immunology)
  • Blotting, Western
  • Cell Line
  • Cells, Cultured
  • Dexamethasone (antagonists & inhibitors, pharmacology)
  • Granulocyte-Macrophage Colony-Stimulating Factor (physiology)
  • Intracellular Signaling Peptides and Proteins
  • Macrophages (immunology)
  • Male
  • Mice
  • NF-kappa B p50 Subunit (analysis, metabolism)
  • Proteins (metabolism, physiology)
  • Spores, Fungal (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: